You are reading 1 of 2 free-access articles allowed for 30 days
Since being established in 2010, the partnership has provided over €4 million in funding for biomedical and clinical science research in Ireland. Research areas have included dietary factors influencing cardiovascular disease, genetics, cell division in cancer and brain memory function.
Successful biomedical and clinical science applications are funded under the following Trust funding schemes: Investigator Awards; Fellowships, including Seed Awards, Collaborative Awards and Strategic Awards. The Wellcome Trust is responsible for the administration of grant applications and awards made under this Partnership.
Commenting on the partnership renewal, Minister for Skills, Research and Innovation Mr Damien English said, “The joint funding will continue to support the best scientists and clinical researchers in Ireland and will continue to boost Ireland’s biomedical research credentials, attracting investment and ultimately creating jobs.”
Dr Jeremy Farrar, Director of the Wellcome Trust, said the partnership with SFI and the HRB “allows us to maximise our support to biomedical researchers in Ireland and builds on the success of those that have been funded previously”. Supporting Irish biomedical researchers “also complements our other activities in Ireland including public engagement, medical humanities and translational research”.
The CEO of the HRB, Dr Graham Love, further commented that it was an “excellent” international partnership that would “deliver for patients”.
Prof Mark Ferguson, Director General of the SFI and Chief Scientific Adviser to the Government, concluded: “Its expansion will see Ireland’s expertise in biomedical and clinic research deepened and through additional funding streams, will open up new opportunities for Irish researchers, helping early career researchers move towards research independence.”